Free Trial

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Birchcliff Energy stock logo

1. Birchcliff Energy OTCMKTS:BIREF

$4.68 -0.11 (-2.30%)
As of 04/3/2025 03:55 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.30 billion
P/E Ratio
33.43
Consensus Rating
Strong Buy
Volume
23,376 shares
Average Volume
120,985 shares
Today's Range
$4.67
$4.87
NexGen Energy stock logo

2. NexGen Energy NYSE:NXE

$4.50 -0.14 (-2.92%)
Closing price 04/3/2025 03:58 PM Eastern
Extended Trading
$4.42 -0.08 (-1.67%)
As of 05:31 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NexGen Energy Ltd., an exploration and development stage company, engages in the acquisition, exploration, and evaluation and development of uranium properties in Canada. More about NexGen Energy

Market Capitalization
$2.56 billion
P/E Ratio
29.97
Consensus Rating
Strong Buy
Volume
12.45 million shares
Average Volume
6.59 million shares
Today's Range
$4.36
$4.59
Denison Mines stock logo

3. Denison Mines NYSEAMERICAN:DNN

$1.24 -0.06 (-4.62%)
Closing price 04/3/2025 04:10 PM Eastern
Extended Trading
$1.25 +0.01 (+0.40%)
As of 05:52 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mines

Market Capitalization
$1.11 billion
P/E Ratio
-124.00
Consensus Rating
Buy
Consensus Price Target
$3.00 (+141.9% Upside)
Volume
61.92 million shares
Average Volume
26.54 million shares
OnKure Therapeutics stock logo

4. OnKure Therapeutics NASDAQ:OKUR

$3.89 -0.24 (-5.81%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$3.93 +0.04 (+1.03%)
As of 04:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$52.27 million
P/E Ratio
-0.32
Consensus Rating
Buy
Consensus Price Target
$32.33 (+731.2% Upside)
Volume
12,610 shares
Average Volume
80,289 shares
OS Therapies stock logo

5. OS Therapies NYSE:OSTX

$1.54 +0.03 (+1.99%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.60 +0.06 (+3.96%)
As of 06:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$33.52 million
Consensus Rating
Buy
Consensus Price Target
$18.00 (+1,068.8% Upside)
Volume
357,045 shares
Average Volume
506,543 shares
Today's Range
$1.46
$1.80
Achieve Life Sciences stock logo

6. Achieve Life Sciences NASDAQ:ACHV

$2.42 -0.13 (-5.10%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$2.68 +0.26 (+10.74%)
As of 05:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. More about Achieve Life Sciences

Market Capitalization
$83.94 million
P/E Ratio
-2.14
Consensus Rating
Buy
Consensus Price Target
$15.75 (+550.8% Upside)
Volume
235,220 shares
Average Volume
174,628 shares
Remove Ads
Stardust Power stock logo

7. Stardust Power NASDAQ:SDST

$0.50 -0.03 (-5.84%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$0.51 +0.00 (+0.79%)
As of 05:47 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$26.66 million
Consensus Rating
Buy
Consensus Price Target
$5.11 (+912.4% Upside)
Volume
208,491 shares
Average Volume
359,296 shares
Today's Range
$0.48
$0.54
Uranium Energy stock logo

8. Uranium Energy NYSEAMERICAN:UEC

$4.45 -0.26 (-5.52%)
Closing price 04/3/2025 04:10 PM Eastern
Extended Trading
$4.42 -0.03 (-0.56%)
As of 06:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Uranium Energy Corp., together with its subsidiaries, engages in exploration, pre-extraction, extraction, and processing uranium and titanium concentrates in the United States, Canada, and Paraguay. More about Uranium Energy

Market Capitalization
$1.88 billion
P/E Ratio
-37.08
Consensus Rating
Buy
Consensus Price Target
$10.60 (+138.2% Upside)
Volume
7.47 million shares
Average Volume
7.51 million shares
enCore Energy stock logo

9. enCore Energy NASDAQ:EU

$1.18 -0.09 (-7.09%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.23 +0.05 (+4.24%)
As of 05:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. More about enCore Energy

Market Capitalization
$236.71 million
P/E Ratio
-4.21
Consensus Rating
Buy
Consensus Price Target
$4.38 (+270.8% Upside)
Volume
2.97 million shares
Average Volume
1.44 million shares
Solid Biosciences stock logo

10. Solid Biosciences NASDAQ:SLDB

$3.40 -0.29 (-7.86%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$3.38 -0.02 (-0.44%)
As of 05:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Solid Biosciences Inc, a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. More about Solid Biosciences

Market Capitalization
$263.48 million
P/E Ratio
-1.12
Consensus Rating
Buy
Consensus Price Target
$15.67 (+360.8% Upside)
Volume
757,581 shares
Average Volume
854,982 shares
Bioceres Crop Solutions stock logo

11. Bioceres Crop Solutions NASDAQ:BIOX

$4.24 -0.25 (-5.57%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$4.36 +0.12 (+2.71%)
As of 04/3/2025 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. More about Bioceres Crop Solutions

Market Capitalization
$265.90 million
P/E Ratio
212.11
Consensus Rating
Buy
Consensus Price Target
$9.88 (+132.9% Upside)
Volume
119,460 shares
Average Volume
161,390 shares
Remove Ads
Quince Therapeutics stock logo

12. Quince Therapeutics NASDAQ:QNCX

$1.26 -0.06 (-4.55%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.22 -0.04 (-3.57%)
As of 04/3/2025 06:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$55.44 million
P/E Ratio
-1.02
Consensus Rating
Buy
Consensus Price Target
$8.00 (+534.9% Upside)
Volume
130,882 shares
Average Volume
244,626 shares
GeoVax Labs stock logo

13. GeoVax Labs NASDAQ:GOVX

$1.10 -0.08 (-6.78%)
As of 04/3/2025 04:00 PM Eastern

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax Labs

Market Capitalization
$11.14 million
P/E Ratio
-0.19
Consensus Rating
Buy
Consensus Price Target
$14.20 (+1,190.9% Upside)
Volume
436,895 shares
Average Volume
611,722 shares
Cardiol Therapeutics stock logo

14. Cardiol Therapeutics NASDAQ:CRDL

$0.91 -0.01 (-1.09%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$0.93 +0.02 (+1.76%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol Therapeutics

Market Capitalization
$75.17 million
P/E Ratio
-2.33
Consensus Rating
Buy
Consensus Price Target
$8.40 (+823.1% Upside)
Volume
205,795 shares
Average Volume
383,791 shares
Reviva Pharmaceuticals stock logo

15. Reviva Pharmaceuticals NASDAQ:RVPH

$0.56 +0.00 (+0.63%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$0.56 +0.00 (+0.09%)
As of 05:26 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$18.84 million
P/E Ratio
-0.51
Consensus Rating
Buy
Consensus Price Target
$10.00 (+1,674.6% Upside)
Volume
806,140 shares
Average Volume
1.09 million shares
Rezolve AI stock logo

16. Rezolve AI NASDAQ:RZLV

$1.45 +0.06 (+4.32%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.46 +0.01 (+0.69%)
As of 06:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rezolve Ai Ltd. operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$249.67 million
Consensus Rating
Buy
Consensus Price Target
$6.00 (+313.8% Upside)
Volume
2.95 million shares
Average Volume
5.17 million shares
Today's Range
$1.27
$1.49
Remove Ads
Nkarta stock logo

17. Nkarta NASDAQ:NKTX

$1.71 -0.20 (-10.47%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.72 +0.02 (+0.88%)
As of 05:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about Nkarta

Market Capitalization
$135.53 million
P/E Ratio
-0.91
Consensus Rating
Buy
Consensus Price Target
$14.86 (+768.8% Upside)
Volume
1.09 million shares
Average Volume
1.09 million shares
Mereo BioPharma Group stock logo

18. Mereo BioPharma Group NASDAQ:MREO

$2.21 -0.16 (-6.75%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$2.23 +0.02 (+0.90%)
As of 06:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$367.70 million
P/E Ratio
-36.83
Consensus Rating
Buy
Consensus Price Target
$7.71 (+249.1% Upside)
Volume
1.19 million shares
Average Volume
1.01 million shares
Full House Resorts stock logo

19. Full House Resorts NASDAQ:FLL

$3.64 -0.60 (-14.15%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$3.80 +0.16 (+4.29%)
As of 06:11 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Full House Resorts, Inc owns, leases, operates, develops, manages, and invests in casinos, and related hospitality and entertainment facilities in the United States. More about Full House Resorts

Market Capitalization
$130.59 million
P/E Ratio
-3.08
Consensus Rating
Buy
Consensus Price Target
$6.33 (+74.0% Upside)
Volume
416,438 shares
Average Volume
125,763 shares
Immunic stock logo

20. Immunic NASDAQ:IMUX

$1.05 -0.06 (-5.41%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.02 -0.03 (-2.38%)
As of 06:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$100.07 million
P/E Ratio
-0.85
Consensus Rating
Buy
Consensus Price Target
$12.67 (+1,106.3% Upside)
Volume
844,011 shares
Average Volume
609,551 shares
Western Copper & Gold stock logo

21. Western Copper & Gold NYSE:WRN

$1.08 -0.02 (-1.82%)
As of 04/3/2025 04:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$220 million
P/E Ratio
-54.00
Consensus Rating
Buy
Consensus Price Target
$4.25 (+293.5% Upside)
Volume
376,655 shares
Average Volume
295,653 shares
PMV Pharmaceuticals stock logo

22. PMV Pharmaceuticals NASDAQ:PMVP

$1.00 -0.01 (-0.50%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.00 +0.01 (+0.50%)
As of 04/3/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PMV Pharmaceuticals, Inc, a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. More about PMV Pharmaceuticals

Market Capitalization
$51.67 million
P/E Ratio
-1.00
Consensus Rating
Buy
Consensus Price Target
$5.50 (+452.8% Upside)
Volume
105,975 shares
Average Volume
274,313 shares
FibroBiologics stock logo

23. FibroBiologics NASDAQ:FBLG

$0.88 -0.06 (-6.56%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$0.91 +0.04 (+4.46%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologics

Market Capitalization
$31.86 million
Consensus Rating
Buy
Consensus Price Target
$13.00 (+1,385.7% Upside)
Volume
197,192 shares
Average Volume
276,360 shares
Today's Range
$0.87
$0.95
Invivyd stock logo

24. Invivyd NASDAQ:IVVD

$0.55 -0.03 (-5.03%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$0.55 +0.00 (+0.55%)
As of 06:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Invivyd, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. More about Invivyd

Market Capitalization
$65.98 million
P/E Ratio
-0.28
Consensus Rating
Buy
Consensus Price Target
$7.89 (+1,334.1% Upside)
Volume
1.71 million shares
Average Volume
4.22 million shares
Ceragon Networks stock logo

25. Ceragon Networks NASDAQ:CRNT

$2.21 -0.23 (-9.43%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$2.22 +0.02 (+0.68%)
As of 04:35 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ceragon Networks Ltd., together with its subsidiaries, provides wireless transport solutions for cellular operators and other wireless service providers in North America, Europe, Africa, the Asia Pacific, the Middle East, India, and Latin America. More about Ceragon Networks

Market Capitalization
$196.33 million
P/E Ratio
8.19
Consensus Rating
Buy
Consensus Price Target
$6.38 (+188.5% Upside)
Volume
1.50 million shares
Average Volume
1.02 million shares